Johnson and Johnson Rilematovir gets CDSCO panel okay for phase 3 trial Medical Dialogues Team18 Aug 2021 4:18 PM ISTNew Delhi: Global pharmaceuticals major Johnson and Johnson (JnJ) has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs...
Torrent Pharma Tapentadol Nasal Spray gets CDSCO panel go ahead for phase 3 trial Medical Dialogues Team17 Aug 2021 3:40 PM ISTNew Delhi: The Ahmedabad-based pharmaceutical major, Torrent Pharma, has received permission from the Subject Expert Committee (SEC) of the Central...
Sun Pharma gets CDSCO panel nod to additional pack size of Gemcitabine Medical Dialogues Team16 Aug 2021 2:00 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Conduct phase 3 trial of Nafamostat Mesilatefor for marketing approval: CDSCO panel tells Cipla Medical Dialogues Team15 Aug 2021 11:30 AM ISTNew Delhi: Rejecting drug maker Cipla's proposal to market and manufacture Nafamostat Mesilate for injection at 50 mg/vial and 100mg/vial, the Subject...
CDSCO grants loan license to PSU for supplying Covaxin drug substance to Bharat Biotech Ruchika Sharma15 Aug 2021 11:00 AM ISTNew Delhi: Hyderabad-based PSU Indian Immunologicals Limited has received a loan license from drug regulator CDSCO for supplying to Bharat Biotech...
Glenmark gets CDSCO panel nod for manufacturing, marketing Itraconazole Capsules Medical Dialogues Team15 Aug 2021 10:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has given its nod to pharma major Glenmark...
JnJ cancer drug Amivantamab gets CDSCO panel okay with waiver of local phase 3,4 trials Medical Dialogues Team14 Aug 2021 3:25 PM ISTNew Delhi: Considering an unmet medical need in the country, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation...
44 drug samples including Cipla Remdesivir fail to qualify CDSCO test, 1 declared misbranded Medical Dialogues Team14 Aug 2021 3:11 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) flagged 44...
Study on mixing of Covaxin, Covishield doses get DCGI okay Ruchika Sharma11 Aug 2021 4:04 PM ISTNew Delhi: India's drug regulator has given approval for a study to be conducted by the Christian Medical College (CMC), Vellore on mixing of COVID-19...
CDSCO asks stakeholders to submit data on rationality, safety, & efficacy of older FDCs Medical Dialogues Team11 Aug 2021 12:55 PM ISTNew Delhi: In order to assess the status of fixed dose combination drugs licensed prior to 1988, the Directorate General of Health Services, Central...
Pfizer Tafamidis to be sold on prescription of cardiologist only: CDSCO panel Medical Dialogues Team10 Aug 2021 5:24 PM ISTNew Delhi: Granting the permission of local clinical trial waver, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Emcure Pharma eyes to be among top 5 drug firms: Official Ruchika Sharma9 Aug 2021 1:00 PM ISTNew Delhi: Emcure Pharmaceuticals is aiming to be among the top five drug firms in the country in the next five to seven years as it also eyes...
